TIOSO-GPS: Patient Specific Instruments Versus Standard Surgical Instruments

Sponsor
The Cleveland Clinic (Other)
Overall Status
Completed
CT.gov ID
NCT01430468
Collaborator
(none)
44
1
2
8
5.5

Study Details

Study Description

Brief Summary

Comparison of Glenoid Component Position Using Patient Specific Instruments Versus Standard Surgical Instruments: A Randomized Prospective Clinical Trial

Condition or Disease Intervention/Treatment Phase
  • Procedure: Glenoid Positioning System
N/A

Detailed Description

This is a non blinded prospective randomized clinical trial to define the efficacy of a new technology developed at the Cleveland Clinic to improve the positioning of the glenoid component in total shoulder arthroplasty. The Cleveland Clinic research team has worked on the development and validation of this new technology for the last six years. The investigators have validated the pre-operative planning software and published the results in the peer review literature (1, 7, 8, 9). The investigators have used this software in the planning of total shoulder surgery over the last three years. The investigators have validated the accuracy and reproducibility of the patient-specific instrumentation in both cadaver shoulders and Sawbones models of the shoulder using multiple surgeons. These studies also validated our ability to precisely measure component position using 3D CT scan imaging after placement of the implants in a pre-clinical cadaver study, thereby validating our ability to accurately measure and compare component position between the groups described in this proposed clinical trial. The investigators have also proven the ability of the software and techniques to produce an accurate representation of the glenoid morphology in patients with osteoarthritis or rotator cuff deficient arthritis in 13 patients. This was an IRB approved patient safety study performed at the Cleveland Clinic. The investigators have performed extensive studies of the materials and processes for the fabrication, sterilization and packaging of the patient specific instruments. The investigators have selected materials and processes that have met all of the FDA requirements for use of these materials and processes as clinical devices in vivo. These devices (non implanted instruments) are generally classified by FDA as a Class I device not having significant clinical risk. The investigators have studied the materials and process to produce accurate instruments that meet the clinical specification for fit onto the surrogate glenoid surfaces and maintain this shape and fit after sterilization. These same patient specific instruments have been tested in pre-clinical trials (Sawbones and Cadavers), demonstrating their ability to perform the functions specified with a high level of accuracy and much better than the use of standard generic instruments.

Study Design

Study Type:
Interventional
Actual Enrollment :
44 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Comparison of Glenoid Component Position Using Patient Specific Instruments Versus Standard Surgical Instruments: A Randomized Prospective Clinical Trial
Study Start Date :
Sep 1, 2010
Actual Primary Completion Date :
May 1, 2011
Actual Study Completion Date :
May 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Experimental: Glenoid Positioning System

For the patients randomized to the GPS group, the surgeon will be given the GPS patient specific instrumentation and a model of the glenoid surface showing the exact placement and fit of the GPS alignment instruments.

Procedure: Glenoid Positioning System
Design and fabrication of patient specific instrument for placement of a guide pin to be used to aid in bone preparation for placement of a metaglene and its fixation screws or anatomic glenoid component

No Intervention: Standard Group

Each surgeon will use their standard methods of pre-operative planning using the pre-operative x-rays and CT scan.

Outcome Measures

Primary Outcome Measures

  1. Comparing Glenoid Component Positioning to Pre Operative Planning [1 month post op]

    Final implant position will be determined by comparing the position of the glenoid component on the post-operative CT scans with the implant position planned pre-operatively on the surgical simulator. These measurements will be in degrees.

Secondary Outcome Measures

  1. Intra-operative Photographs [Intra-operative]

    Intra-operative photographs will be used to qualitatively, not quantitatively, to document the surgical steps and may be useful to explain a deviation in the surgery than what would have been expected by the pre-operative simulator. No quantitative data will be collected from the photographs.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All patients otherwise indicated for primary reverse or anatomic total shoulder replacement that are able to get a pre-operative CT scan at the Cleveland Clinic will be considered eligible for enrollment. All patients will be consented in the office as part of the pre-operative consent for surgery and all will need to randomization at the time of surgery
Exclusion Criteria:
  • Patients will be excluded if they have significant metal in the joint that results in metal artifact on the CT scan, thereby compromising the ability to visualize the glenoid on the pre-operative simulator.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cleveland Clinic Cleveland Ohio United States 44195

Sponsors and Collaborators

  • The Cleveland Clinic

Investigators

  • Principal Investigator: Joseph P. Iannotti, MD, PhD, The Cleveland Clinic

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Joseph Iannotti, Institute Chairman, The Cleveland Clinic
ClinicalTrials.gov Identifier:
NCT01430468
Other Study ID Numbers:
  • CCF 10-582
  • TECH 09-073
First Posted:
Sep 8, 2011
Last Update Posted:
Jun 1, 2020
Last Verified:
Jan 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Joseph Iannotti, Institute Chairman, The Cleveland Clinic

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Glenoid Positioning System Standard Group
Arm/Group Description For the patients randomized to the GPS group, the surgeon will be given the GPS patient specific instrumentation and a model of the glenoid surface showing the exact placement and fit of the GPS alignment instruments. Glenoid Positioning System: Design and fabrication of patient specific instrument for placement of a guide pin to be used to aid in bone preparation for placement of a metaglene and its fixation screws or anatomic glenoid component Each surgeon will use their standard methods of pre-operative planning using the pre-operative x-rays and CT scan.
Period Title: Overall Study
STARTED 22 22
COMPLETED 15 16
NOT COMPLETED 7 6

Baseline Characteristics

Arm/Group Title Glenoid Positioning System Standard Group Total
Arm/Group Description For the patients randomized to the GPS group, the surgeon will be given the GPS patient specific instrumentation and a model of the glenoid surface showing the exact placement and fit of the GPS alignment instruments. Glenoid Positioning System: Design and fabrication of patient specific instrument for placement of a guide pin to be used to aid in bone preparation for placement of a metaglene and its fixation screws or anatomic glenoid component Each surgeon will use their standard methods of pre-operative planning using the pre-operative x-rays and CT scan. Total of all reporting groups
Overall Participants 15 16 31
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
69.1
(6.8)
67.3
(9.5)
68.2
(8.2)
Sex: Female, Male (Count of Participants)
Female
8
53.3%
11
68.8%
19
61.3%
Male
7
46.7%
5
31.3%
12
38.7%
Region of Enrollment (participants) [Number]
United States
15
100%
16
100%
31
100%
Pre-operative retroversion (Degrees) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [Degrees]
-14.8
(10.1)
-11.3
(13.3)
-13.0
(11.8)

Outcome Measures

1. Primary Outcome
Title Comparing Glenoid Component Positioning to Pre Operative Planning
Description Final implant position will be determined by comparing the position of the glenoid component on the post-operative CT scans with the implant position planned pre-operatively on the surgical simulator. These measurements will be in degrees.
Time Frame 1 month post op

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Glenoid Positioning System Standard Group
Arm/Group Description For the patients randomized to the GPS group, the surgeon will be given the GPS patient specific instrumentation and a model of the glenoid surface showing the exact placement and fit of the GPS alignment instruments. Glenoid Positioning System: Design and fabrication of patient specific instrument for placement of a guide pin to be used to aid in bone preparation for placement of a metaglene and its fixation screws or anatomic glenoid component Each surgeon will use their standard methods of pre-operative planning using the pre-operative x-rays and CT scan.
Measure Participants 15 16
Mean (Standard Deviation) [Degrees]
4.3
(4.5)
6.9
(4.4)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Glenoid Positioning System, Standard Group
Comments The absolute difference between the actual outcome and the planned outcome was compared between the standard surgical group and the glenoid positioning system group with use of a Student t test. Results were considered to be significant at p < 0.05.
Type of Statistical Test Equivalence
Comments With use of previously established criteria for a malpositioned glenoid, deviations of greater than 10 degrees of version from the planned placement were considered relevant.
Statistical Test of Hypothesis p-Value 0.11
Comments P-value was calculated. Threshold for statistical significance (p<0.05)
Method t-test, 2 sided
Comments
2. Secondary Outcome
Title Intra-operative Photographs
Description Intra-operative photographs will be used to qualitatively, not quantitatively, to document the surgical steps and may be useful to explain a deviation in the surgery than what would have been expected by the pre-operative simulator. No quantitative data will be collected from the photographs.
Time Frame Intra-operative

Outcome Measure Data

Analysis Population Description
Number participants with deviation in the surgery than expected by the pre-operative simulator.
Arm/Group Title Glenoid Positioning System Standard Group
Arm/Group Description For the patients randomized to the GPS group, the surgeon will be given the GPS patient specific instrumentation and a model of the glenoid surface showing the exact placement and fit of the GPS alignment instruments. Glenoid Positioning System: Design and fabrication of patient specific instrument for placement of a guide pin to be used to aid in bone preparation for placement of a metaglene and its fixation screws or anatomic glenoid component Each surgeon will use their standard methods of pre-operative planning using the pre-operative x-rays and CT scan.
Measure Participants 15 16
Count of Participants [Participants]
0
0%
0
0%

Adverse Events

Time Frame
Adverse Event Reporting Description
Arm/Group Title Glenoid Positioning System Standard Group
Arm/Group Description For the patients randomized to the GPS group, the surgeon will be given the GPS patient specific instrumentation and a model of the glenoid surface showing the exact placement and fit of the GPS alignment instruments. Glenoid Positioning System: Design and fabrication of patient specific instrument for placement of a guide pin to be used to aid in bone preparation for placement of a metaglene and its fixation screws or anatomic glenoid component Each surgeon will use their standard methods of pre-operative planning using the pre-operative x-rays and CT scan.
All Cause Mortality
Glenoid Positioning System Standard Group
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/15 (0%) 0/16 (0%)
Serious Adverse Events
Glenoid Positioning System Standard Group
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/15 (0%) 0/16 (0%)
Other (Not Including Serious) Adverse Events
Glenoid Positioning System Standard Group
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/15 (0%) 0/16 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Joseph P. Iannotti, MD, PhD
Organization Cleveland Clinic Foundation
Phone 216-445-5151
Email iannotj@ccf.org
Responsible Party:
Joseph Iannotti, Institute Chairman, The Cleveland Clinic
ClinicalTrials.gov Identifier:
NCT01430468
Other Study ID Numbers:
  • CCF 10-582
  • TECH 09-073
First Posted:
Sep 8, 2011
Last Update Posted:
Jun 1, 2020
Last Verified:
Jan 1, 2020